Evaluation of Autogenous Demineralized Dentin Graft Vs Autogenous Bone Graft in Management of Intrabony Defects
Launched by CAIRO UNIVERSITY · Sep 19, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of grafts used to treat specific dental issues known as intrabony periodontal defects, which are pockets of bone loss in the gums. The goal is to compare the effectiveness of autogenous demineralized dentin—made from the patient's own teeth—against traditional autogenous bone grafts taken from another area of the patient's mouth. Both procedures aim to improve dental health by enhancing bone and tissue attachment. Participants will undergo initial treatments to clean their teeth and prepare for surgery, and then they will receive one of the two grafts using a minimally invasive surgical technique.
To be eligible for this trial, participants need to be at least 18 years old and willing to follow oral hygiene instructions. They should have specific dental conditions, such as a probing depth of 5 mm or more in their gums. Patients with certain health issues or those who smoke cannot participate. Throughout the trial, participants will have follow-up appointments at 1, 3, and 6 months to assess their recovery and the success of the grafting procedure based on various dental health indicators. This study will help determine if the new grafting material is as effective as the standard treatment, which could improve how dental professionals manage these types of gum issues in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Patient-related criteria:
- • Motivated patient 18 years of age or order.
- • Patient consulting in the outpatient clinic.
- • Patient ready to perform oral hygiene instructions.
- • Provide informed consent.
- • Accepts the 6 months follow-up period.
- * Teeth related criteria:
- • Tooth with two or three-walled intra-bony defect, probing depth ≥ 5mm with intra osseous defect ≥ 3mm.
- • Mature permanent tooth.
- • Unrestorable tooth or fractured tooth beyond restoration, impacted third molar or supernumerary tooth to be extracted and used as whole tooth graft inside the intrabony defect.
- Exclusion Criteria:
- * Patient-related criteria:
- • Medically compromised patients.
- • Pregnant women.
- • Uncooperative patients.
- • Smokers.
- • Systemic diseases that may compromise healing or bone metabolism (e.g diabetes, hyperthyroidism).
- • Failure to maintain good oral hygiene.
- * Teeth related criteria:
- • Teeth with supra-bony defects.
- • Teeth with grade III mobility.
- • Teeth having interproximal craters, grade III furcation involvement, and grade III mobility.
- • Presence of caries or overhanging restorations.
- • Presence of peri-apical injuries.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Ghada M. Abouhussein, Bachelor
Principal Investigator
Cairo University
Weam El-Battawy, Ass professor
Study Director
Cairo University
Nesma Shemais, Ass lecturer
Study Chair
Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported